Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00108550 · ClinicalTrials.gov registry record · Phase 2
Chronic Low Back Pain Research Project
A Phase 2 study of Chronic Low Back Pain, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
- 108
- Enrollment target
- 1
- Study location
NCT00108550 is a Phase 2 study of Chronic Low Back Pain that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 108 participants, below the 591-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00108550, a Phase 2 study of Chronic Low Back Pain, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 108 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether gabapentin is efficacious as an analgesic for chronic low back pain.
Conditions Studied
Interventions
- DRUG gabapentin
- DRUG Inert placebo
Study Locations (1)
California
- VA San Diego Healthcare System, San Diego - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2004-10 |
| Est. Completion | 2009-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00108550
The ClinicalTrials.gov registry entry for NCT00108550 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 591-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (82% lower). The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which gabapentin is the first listed.
NCT00108550 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00108550 about?
NCT00108550 is a clinical study titled "Chronic Low Back Pain Research Project". The purpose of this study is to determine whether gabapentin is efficacious as an analgesic for chronic low back pain.
What is the current status of trial NCT00108550?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 108 participants. The study started on 2004-10. Estimated completion is 2009-09.
What conditions does trial NCT00108550 study?
This clinical trial studies the following conditions: Chronic Low Back Pain.
What interventions are being tested in trial NCT00108550?
The interventions under investigation include: gabapentin (DRUG), Inert placebo (DRUG).
Who is sponsoring clinical trial NCT00108550?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00108550 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression
RECRUITING · Phase 2
-
Modulation Effect of tACS on Chronic Low Back Pain
RECRUITING · Phase 2
-
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
RECRUITING · Phase 2
-
Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure
ACTIVE NOT RECRUITING · Phase 2
-
Low-Dose Naltrexone and Acetaminophen Combination in the Treatment of Chronic Low Back Pain (ANODYNE-4)
COMPLETED · Phase 2
-
Treating Negative Affect in Low Back Pain Patients
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.